SOURCE: Vivakor, Inc.

January 26, 2010 08:00 ET

Vivakor Announces Launch of New Product Research, VivaAuris

CORALVILLE, IA--(Marketwire - January 26, 2010) - Vivakor, Inc. (OTCBB: VIVK) today announced the launch of a research division, VivaAuris. In line with Vivakor's emphasis on research and development of products in the areas of detection and prevention, the VivaAuris division will focus on detection of auditory conditions, which fits neatly with the Company's overall development strategy. The first product in development for the newly launched division is the Opti-Ear detection device, which will be used for at-home detection of the symptoms of middle ear infections. This device is intended to assist parents and caregivers in determining the need for further physician examination.

Vivakor Executive Chairman, Matt Nicosia, discussed the timing and the potential for this new division. "With the continuing efforts in our VivaSight division's optics technology, the VivaAuris division was launched to continue that progression in optics, but with a focus on auditory conditions. The fact that we are able to develop new devices with immediate commercial potential from shared technology, but in different markets, is another validation of our technology commercialization model. We believe the potential market for the Opti-Ear product could be greater than $10 million annually." Clinical and validation studies are expected to commence in summer of 2010.

About Vivakor, Inc.

Vivakor is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at


This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products, markets and business strategies. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

Contact Information

  • Contact:
    Vivakor Investor Relations
    c/o IME Advisors
    (888) 648-8485